What's Happening?
The Department of Otolaryngology-Head & Neck Surgery has received a significant gift from the Steve and Marian Mosites Family Foundation. This donation is specifically allocated to advance precision medicine research in head and neck cancer, funding two
projects through the Mosites Precision Medicine Awards for 2026. The award recipients are Matthew Spector, MD, FACS, for his project titled 'Personalized Implant-Radiation Strategies for Head and Neck Cancer Reconstruction,' and Lazar Vujanovic, PhD, for his project 'Defining the Postoperative Immune Landscape in Oral Cavity Cancer via Surgical Drain Fluid.' Dr. Spector's research aims to explore personalized mandibular reconstruction using novel CFR-PEEK implants to improve radiation delivery and healing. Dr. Vujanovic's project will study the immune environment immediately after surgery using surgical drain fluid to understand anti-tumor immune responses and identify patients who might benefit from more personalized treatments. The initiative honors Marian Mosites, who was a head and neck cancer patient in the 1990s.
Why It's Important?
This funding is critical for advancing personalized medicine in head and neck cancer, particularly as government research funding becomes increasingly limited. The Mosites Precision Medicine Award provides essential early investment, enabling researchers to pursue innovative ideas that might otherwise lack initial support. Dr. Spector's work on personalized implants could lead to improved patient outcomes by enhancing the effectiveness of radiation therapy and accelerating healing, directly impacting the quality of life for head and neck cancer patients. Dr. Vujanovic's research into the postoperative immune environment offers a unique opportunity to understand why some patients relapse and to identify those who would benefit most from tailored treatments, potentially leading to more effective and targeted therapies. Such philanthropic contributions are vital for generating the preliminary data necessary to secure larger national grants, thereby accelerating the translation of groundbreaking research into clinical practice.
What's Next?
The immediate next steps involve the execution of the two funded research projects by Dr. Spector and Dr. Vujanovic. Dr. Spector will focus on developing and testing personalized mandibular reconstruction techniques with novel CFR-PEEK implants, aiming to gather data on their efficacy in improving radiation delivery and patient healing. Dr. Vujanovic will proceed with studying immune cells collected from surgical drain fluid to define the postoperative immune landscape in oral cavity cancer, with the goal of identifying biomarkers for relapse and personalized treatment responses. The success of these initial projects is expected to generate preliminary data that will be crucial for competing for larger national grants, which can further expand the scope and impact of this research. The long-term vision is to translate these findings into new, personalized treatment strategies that improve outcomes for head and neck cancer patients.
Beyond the Headlines
This initiative highlights the growing role of private philanthropy in driving medical innovation, especially in areas where public funding may be constrained. The focus on personalized medicine reflects a broader trend in oncology towards tailoring treatments to individual patient characteristics, moving away from a one-size-fits-all approach. Ethically, this shift promises more effective treatments with fewer side effects, but it also raises questions about the accessibility and cost of highly individualized therapies. The research into postoperative immune responses could also have broader implications for understanding cancer recurrence and developing immunotherapies across various cancer types. Furthermore, the legacy of Marian Mosites, a former patient, underscores the powerful connection between personal experience, philanthropic giving, and scientific advancement, demonstrating how individual stories can inspire significant contributions to medical research and patient care.
